248 related articles for article (PubMed ID: 15182226)
21. In situ formation of protease-resistant prion protein in transmissible spongiform encephalopathy-infected brain slices.
Bessen RA; Raymond GJ; Caughey B
J Biol Chem; 1997 Jun; 272(24):15227-31. PubMed ID: 9182546
[TBL] [Abstract][Full Text] [Related]
22. Evolving views in prion glycosylation: functional and pathological implications.
Ermonval M; Mouillet-Richard S; Codogno P; Kellermann O; Botti J
Biochimie; 2003; 85(1-2):33-45. PubMed ID: 12765773
[TBL] [Abstract][Full Text] [Related]
23. Detection of PrP in extraneural tissues.
Brown KL; Ritchie DL; McBride PA; Bruce ME
Microsc Res Tech; 2000 Jul; 50(1):40-5. PubMed ID: 10871547
[TBL] [Abstract][Full Text] [Related]
24. The transmissible spongiform encephalopathies of livestock.
Greenlee JJ; Greenlee MH
ILAR J; 2015; 56(1):7-25. PubMed ID: 25991695
[TBL] [Abstract][Full Text] [Related]
25. The pathogenic mechanisms of prion diseases.
Hur K; Kim JI; Choi SI; Choi EK; Carp RI; Kim YS
Mech Ageing Dev; 2002 Nov; 123(12):1637-47. PubMed ID: 12470901
[TBL] [Abstract][Full Text] [Related]
26. Involvement of trace elements in the pathogenesis of prion diseases.
Mizuno D; Koyama H; Ohkawara S; Sadakane Y; Kawahara M
Curr Pharm Biotechnol; 2014; 15(11):1049-57. PubMed ID: 25373386
[TBL] [Abstract][Full Text] [Related]
27. Reconstructing prions: fibril assembly from simple yeast to complex mammals.
Sigurdson C; Polymenidou M; Aguzzi A
Neurodegener Dis; 2005; 2(1):1-5. PubMed ID: 16908997
[TBL] [Abstract][Full Text] [Related]
28. Novel aspects of prions, their receptor molecules, and innovative approaches for TSE therapy.
Vana K; Zuber C; Nikles D; Weiss S
Cell Mol Neurobiol; 2007 Feb; 27(1):107-28. PubMed ID: 17151946
[TBL] [Abstract][Full Text] [Related]
29. Species-barrier phenomenon in prion transmissibility from a viewpoint of protein science.
Hagiwara K; Hara H; Hanada K
J Biochem; 2013 Feb; 153(2):139-45. PubMed ID: 23284000
[TBL] [Abstract][Full Text] [Related]
30. Biochemical Characterization of Prions.
Fiorini M; Bongianni M; Monaco S; Zanusso G
Prog Mol Biol Transl Sci; 2017; 150():389-407. PubMed ID: 28838671
[TBL] [Abstract][Full Text] [Related]
31. Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides.
Soto C; Kascsak RJ; Saborío GP; Aucouturier P; Wisniewski T; Prelli F; Kascsak R; Mendez E; Harris DA; Ironside J; Tagliavini F; Carp RI; Frangione B
Lancet; 2000 Jan; 355(9199):192-7. PubMed ID: 10675119
[TBL] [Abstract][Full Text] [Related]
32. Prion protein misfolding and disease.
Moore RA; Taubner LM; Priola SA
Curr Opin Struct Biol; 2009 Feb; 19(1):14-22. PubMed ID: 19157856
[TBL] [Abstract][Full Text] [Related]
33. A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins.
Lee DC; Stenland CJ; Miller JL; Cai K; Ford EK; Gilligan KJ; Hartwell RC; Terry JC; Rubenstein R; Fournel M; Petteway SR
Transfusion; 2001 Apr; 41(4):449-55. PubMed ID: 11316893
[TBL] [Abstract][Full Text] [Related]
34. New approaches for the selection and evaluation of anti-prion organic compounds.
Cordeiro Y; Ferreira NC
Mini Rev Med Chem; 2015; 15(2):84-92. PubMed ID: 25723455
[TBL] [Abstract][Full Text] [Related]
35. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
[TBL] [Abstract][Full Text] [Related]
36. Progress on low susceptibility mechanisms of transmissible spongiform encephalopathies.
Qing LL; Zhao H; Liu LL
Dongwuxue Yanjiu; 2014 Sep; 35(5):436-45. PubMed ID: 25297084
[TBL] [Abstract][Full Text] [Related]
37. Recombinant human prion protein fragment 90-231, a useful model to study prion neurotoxicity.
Corsaro A; Thellung S; Villa V; Nizzari M; Aceto A; Florio T
OMICS; 2012; 16(1-2):50-9. PubMed ID: 22321015
[TBL] [Abstract][Full Text] [Related]
38. Factors affecting interactions between prion protein isoforms.
Caughey B; Baron GS
Biochem Soc Trans; 2002 Aug; 30(4):565-9. PubMed ID: 12196138
[TBL] [Abstract][Full Text] [Related]
39. Prion diseases and their biochemical mechanisms.
Cobb NJ; Surewicz WK
Biochemistry; 2009 Mar; 48(12):2574-85. PubMed ID: 19239250
[TBL] [Abstract][Full Text] [Related]
40. Conformational conversion of prion protein in prion diseases.
Zhou Z; Xiao G
Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):465-76. PubMed ID: 23580591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
